注冊 | 登錄讀書好,好讀書,讀好書!
讀書網(wǎng)-DuShu.com
當(dāng)前位置: 首頁出版圖書科學(xué)技術(shù)航空、航天航空、航天醫(yī)學(xué)血管內(nèi)皮功能診斷:循環(huán)系統(tǒng)疾病管理的評價指標(biāo)與實(shí)踐

血管內(nèi)皮功能診斷:循環(huán)系統(tǒng)疾病管理的評價指標(biāo)與實(shí)踐

血管內(nèi)皮功能診斷:循環(huán)系統(tǒng)疾病管理的評價指標(biāo)與實(shí)踐

定 價:¥60.00

作 者: 東條 美奈子[日] 著,王宏宇 譯
出版社: 北京大學(xué)醫(yī)學(xué)出版社
叢編項(xiàng):
標(biāo) 簽: 暫缺

ISBN: 9787565922718 出版時間: 2020-11-01 包裝: 平裝
開本: 16開 頁數(shù): 字?jǐn)?shù):  

內(nèi)容簡介

  本書分為7個大章節(jié),分別為:血管內(nèi)皮功能總論、血管內(nèi)皮功能檢測方法、血管內(nèi)皮功能檢測所提供的信息、血管內(nèi)皮功能異常導(dǎo)致的疾病發(fā)展因素、血管內(nèi)皮功能提供的臨床依據(jù)、心血管疾病與血管內(nèi)皮功能的相關(guān)因素、臨床中血管內(nèi)皮功能應(yīng)用實(shí)踐。目前心血管疾病已成為人類健康的第一殺手,血管健康與心血管健康息息相關(guān),血管健康正是確保身體健康長壽的關(guān)鍵。本書覆蓋了血管健康的基礎(chǔ)理論、臨床診斷、應(yīng)用實(shí)踐等方面,匯集了多個相關(guān)領(lǐng)域的醫(yī)生和學(xué)者的智慧,力求提供血管內(nèi)皮功能的基礎(chǔ)知識以及全新的臨床知識。

作者簡介

  王宏宇,男,漢族,1967年12月出生,山西大同人,醫(yī)學(xué)博士,北京大學(xué)教授,心臟和血管醫(yī)學(xué)專業(yè)主任醫(yī)師,博士/碩士生導(dǎo)師。國家重點(diǎn)研發(fā)計(jì)劃“高可信強(qiáng)智能的心腦血管疾病診療服務(wù)模式解決方案”課題負(fù)責(zé)人,北京大學(xué)首鋼醫(yī)院副院長兼血管醫(yī)學(xué)中心主任,北京大學(xué)醫(yī)學(xué)部血管健康研究中心主任,北京大學(xué)醫(yī)學(xué)部血管疾病社區(qū)防治中心主任,北京大學(xué)臨床研究所心臟和血管健康研究中心主任,分子心血管學(xué)教育部重點(diǎn)實(shí)驗(yàn)室特聘教授,北京大學(xué)醫(yī)學(xué)部睡眠醫(yī)學(xué)中心和北京大學(xué)睡眠研究中心專家委員會委員,北京大學(xué)醫(yī)學(xué)部血管醫(yī)學(xué)、北京大學(xué)血管探秘課程教研室主任。1997年開始進(jìn)行血管功能研究,2004年作為國家衛(wèi)生部十年百項(xiàng)計(jì)劃“血管病變早期檢測技術(shù)推廣”項(xiàng)目負(fù)責(zé)人,在國際上率先提出血管病變早期檢測系統(tǒng),組織制訂了國際上第一個血管病變早期檢測技術(shù)應(yīng)用指南,2010年4月創(chuàng)建了我國第一家血管醫(yī)學(xué)專業(yè)臨床診療中心—北京大學(xué)首鋼醫(yī)院血管醫(yī)學(xué)中心,2011年和2019年分別主持我國針對血管健康管理與預(yù)后心血管疾病關(guān)系的人群隊(duì)列研究和多中心臨床干預(yù)研究(BEST,NCT02569268;EndoFIND,NCT04013204)。目前已發(fā)表學(xué)術(shù)文章240余篇,其中SCI收錄文章26篇。主編我國第一部血管醫(yī)學(xué)領(lǐng)域?qū)V堆懿W(xué)》(北京:人民軍醫(yī)出版社,2006)和《中國血管健康行科普系列叢書》(共8冊)(北京:北京大學(xué)醫(yī)學(xué)出版社,2011)等著作10余部。主持和負(fù)責(zé)多項(xiàng)北京市和國家科研項(xiàng)目。獲“北京市優(yōu)秀人才”稱號,為北京大學(xué)醫(yī)學(xué)部優(yōu)秀教師、首屆北京大學(xué)“臨床醫(yī)療獎”獲得者。目前擔(dān)任國際血管健康學(xué)會(International Society of Vascular Health,ISVH)執(zhí)行委員會委員,國際血管健康學(xué)會中國分會主席,美國高血壓學(xué)會院士(Fellow of American Society of Hypertension,F(xiàn)ASH),中國醫(yī)藥教育協(xié)會血管醫(yī)學(xué)專業(yè)委員會主任委員,中日醫(yī)學(xué)科技交流協(xié)會心臟和血管醫(yī)學(xué)專業(yè)委員會主任委員,中國心臟和血管健康學(xué)院院長,中央電視臺紀(jì)錄頻道(CCTV-9)和《健康之路》欄目、北京電視臺《健康北京》和《養(yǎng)生堂》欄目特邀專家,《中國循環(huán)雜志》等國內(nèi)外多家專業(yè)雜志的編委。

圖書目錄

 第一章 血管內(nèi)皮功能總論 ···············································································1
一、血管內(nèi)皮細(xì)胞的作用 ················································································1
二、血管內(nèi)皮功能異常的機(jī)制 ··········································································3
三、血管內(nèi)皮功能異常反映出的問題 ·································································9
四、血管內(nèi)皮功能檢測的臨床應(yīng)用 ·································································· 10
五、血管內(nèi)皮功能障礙到動脈硬化 ·································································· 12
六、血管內(nèi)皮功能異常導(dǎo)致冠狀動脈痙攣性心絞痛 ············································· 15
七、當(dāng)前血管內(nèi)皮功能為何受到關(guān)注? ···························································· 16
八、血管內(nèi)皮功能在循環(huán)系統(tǒng)預(yù)防醫(yī)學(xué)中的定位 ················································ 16
第二章 血管內(nèi)皮功能檢測技術(shù) ······································································· 21
一、體積描記法 ·························································································· 21
二、 基于血管超聲檢測的血流介導(dǎo)的血管擴(kuò)張 ··················································· 21
三、 可替代FMD 的踝肱指數(shù)輕度異常值 ·························································· 22
四、 指端脈搏波反應(yīng)性充血外周動脈張力 ························································· 23
五、FMD 與RHI 的區(qū)別 ··············································································· 24
六、前臂充血與上臂充血 ·············································································· 25
七、反映血管內(nèi)皮功能的生物標(biāo)志物 ······························································· 25
八、冠狀動脈的內(nèi)皮功能 ·············································································· 28
第三章 血管內(nèi)皮功能檢測所提供的信息 ··························································· 31
一、血管內(nèi)皮功能檢測的篩查作用 ·································································· 31
二、血管內(nèi)皮功能檢測是動脈硬化進(jìn)程的評價指標(biāo) ············································· 31
三、預(yù)測冠狀動脈疾病的預(yù)后 ········································································ 32
四、冠狀動脈痙攣性心絞痛的診斷 ·································································· 33
五、心臟微血管障礙的診斷與療效評估 ···························································· 33
六、深靜脈血栓癥的篩查 ·············································································· 34
七、預(yù)測外周動脈疾病的預(yù)后 ········································································ 35
目 錄
2 血管內(nèi)皮功能診斷——循環(huán)系統(tǒng)疾病管理的評價指標(biāo)與實(shí)踐
第四章 血管內(nèi)皮功能障礙相關(guān)疾病的發(fā)病機(jī)制 ·················································· 39
一、一氧化氮 ····························································································· 39
二、炎癥 ··································································································· 40
三、氧化應(yīng)激 ····························································································· 40
四、自主神經(jīng) ····························································································· 42
第五章 血管內(nèi)皮功能提供的臨床依據(jù) ······························································ 45
一、血管內(nèi)皮功能相關(guān)的基礎(chǔ)研究 ·································································· 45
二、血管內(nèi)皮功能的臨床研究 ········································································ 46
第六章 心血管病及血管內(nèi)皮功能的相關(guān)因素 ····················································· 51
一、冠狀動脈疾病家族史 ·············································································· 51
二、少鹽 ··································································································· 51
三、吸煙 ··································································································· 52
四、高血壓 ································································································ 52
五、糖尿病、糖代謝異常 ·············································································· 53
六、脂質(zhì)異常 ····························································································· 54
七、高尿酸血癥 ·························································································· 55
八、慢性腎病 ····························································································· 55
九、肥胖、代謝綜合征 ················································································· 56
十、睡眠呼吸暫停綜合征 ·············································································· 57
十一、運(yùn)動、體育鍛煉 ················································································· 57
十二、高齡與性別 ······················································································· 59
十三、心律不齊 ·························································································· 59
十四、動脈硬化性疾病 ················································································· 59
十五、靜脈血栓栓塞癥 ················································································· 61
十六、心力衰竭 ·························································································· 63
十七、肺動脈高壓 ······················································································· 64
十八、血流動力學(xué)狀態(tài) ················································································· 64
十九、抑郁癥 ····························································································· 65
二十、維生素、礦物質(zhì) ················································································· 65
二十一、不飽和脂肪酸 ················································································· 66
第七章 血管內(nèi)皮功能在臨床中的應(yīng)用實(shí)踐 ························································ 73
一、肥胖患者的減重指導(dǎo) ·············································································· 74
 目 錄 3
二、預(yù)防動脈硬化的心血管疾病管理 ······························································· 74
三、心臟康復(fù)的風(fēng)險分層與效果評價 ······························································· 77
四、評價預(yù)防缺血性心臟病復(fù)發(fā)的干預(yù)治療效果 ················································ 78
五、心力衰竭的療效評價 ·············································································· 79
六、預(yù)測心血管不良事件的發(fā)生 ····································································· 80
后記············································································································ 83
縮略詞一覽表································································································ 84
索引············································································································ 88
作者簡介······································································································ 90

本目錄推薦

掃描二維碼
Copyright ? 讀書網(wǎng) ranfinancial.com 2005-2020, All Rights Reserved.
鄂ICP備15019699號 鄂公網(wǎng)安備 42010302001612號